- Home
- BCAB vs OM Comparison
BCAB vs OM Comparison
Compare BCAB & OM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BCAB | OM |
|---|---|---|
| Founded | 2007 | 2003 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 71.6M | 85.0M |
| IPO Year | 2020 | 2020 |
Fundamental Metrics
Financial Performance| Metric | BCAB | OM |
|---|---|---|
| Price | $0.77 | $4.45 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 3 | 3 |
| Target Price | $1.00 | ★ $16.00 |
| AVG Volume (30 Days) | ★ 2.1M | 676.5K |
| Earning Date | 11-13-2025 | 11-10-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $120,069,000.00 |
| Revenue This Year | N/A | $5.77 |
| Revenue Next Year | N/A | $9.12 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 4.65 |
| 52 Week Low | $0.24 | $4.00 |
| 52 Week High | $1.65 | $25.35 |
Technical Indicators
Market Signals| Indicator | BCAB | OM |
|---|---|---|
| Relative Strength Index (RSI) | 46.99 | 27.52 |
| Support Level | $0.79 | $4.07 |
| Resistance Level | $0.90 | $4.97 |
| Average True Range (ATR) | 0.14 | 0.37 |
| MACD | -0.02 | 0.32 |
| Stochastic Oscillator | 12.90 | 35.77 |
Price Performance
Historical ComparisonAbout BCAB BioAtla Inc.
BioAtla Inc is a clinical-stage biopharmaceutical company. The company is engaged in the development of a novel class of specific and selective antibody-based therapeutics for the treatment of solid tumor cancer. Its pipeline products comprise mecbotamab vedotin (BA3011), ozuriftamab vedotin (BA3021), and evalstotug (BA3071), and its Phase 1 clinical trial of BA3182 (CAB-EpCAM x CAB-CD3) and Bispecific antibody programs.
About OM Outset Medical Inc.
Outset Medical Inc is a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis. The Company generates revenue from the sales of Tablo consoles and related consumables, including Tablo cartridges and accessories.